199 related articles for article (PubMed ID: 38206689)
21. Case Report: Coexistence of Multiple Myeloma and Auricular Chondritis in VEXAS Syndrome.
Matsumoto H; Fujita Y; Fukatsu M; Ikezoe T; Yokose K; Asano T; Tsuchida N; Maeda A; Yoshida S; Hashimoto H; Temmoku J; Matsuoka N; Yashiro-Furuya M; Sato S; Murakami M; Sato H; Sakuma C; Kawashima K; Shakespear N; Uchiyama Y; Watanabe H; Kirino Y; Matsumoto N; Migita K
Front Immunol; 2022; 13():897722. PubMed ID: 35757758
[TBL] [Abstract][Full Text] [Related]
22. [Two cases of VEXAS syndrome].
Gunnarsson K; Vivar Pomiano N; Tesi B; Tobiasson M; Creignou M; Ungerstedt J
Lakartidningen; 2022 Sep; 119():. PubMed ID: 36082915
[TBL] [Abstract][Full Text] [Related]
23. Case report: diagnosis of VEXAS syndrome in a patient with therapy-resistant large vessel vasculitis.
Boret M; Malfait T
Acta Clin Belg; 2024 Apr; 79(2):143-147. PubMed ID: 38314661
[TBL] [Abstract][Full Text] [Related]
24. A clinical, histopathological, and molecular study of two cases of VEXAS syndrome without a definitive myeloid neoplasm.
Li P; Venkatachalam S; Ospina Cordona D; Wilson L; Kovacsovics T; Moser KA; Miles RR; Beck DB; George T; Tantravahi SK
Blood Adv; 2022 Jan; 6(2):405-409. PubMed ID: 34649277
[TBL] [Abstract][Full Text] [Related]
25. VEXAS: is it time to reshape the nosology of clonal hematopoiesis?
Sujobert P; Largeaud L; Jamilloux Y; Heiblig M; Kosmider O
Expert Rev Hematol; 2023; 16(7):495-499. PubMed ID: 37119011
[TBL] [Abstract][Full Text] [Related]
26. A man in his sixties with chondritis and bone marrow failure.
Midtvedt Ø; Stray-Pedersen A; Andersson H; Gunnarsson R; Tveten K; Ali MM; Tjønnfjord GE
Tidsskr Nor Laegeforen; 2022 Mar; 142(4):. PubMed ID: 35239266
[TBL] [Abstract][Full Text] [Related]
27. VEXAS syndrome: A review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolation.
Cherniawsky H; Friedmann J; Nicolson H; Dehghan N; Stubbins RJ; Foltz LM; Leitch HA; Sreenivasan GM; Ambler KLS; Nevill TJ; McGinnis E; Wilson L; Beck DB; Chen LYC; Marcon KM
Eur J Haematol; 2023 Jun; 110(6):633-638. PubMed ID: 36788756
[TBL] [Abstract][Full Text] [Related]
28. Case report: VEXAS syndrome: an atypical indolent presentation as sacroiliitis with molecular response to azacitidine.
Pereira da Costa R; Sapinho G; Bandeira M; Infante J; Marques T; Mimoso Santos C; Forjaz de Lacerda J; Fonseca JE; Romeu JC
Front Immunol; 2024; 15():1403808. PubMed ID: 38840907
[TBL] [Abstract][Full Text] [Related]
29. Vacuoles in bone marrow progenitors: VEXAS syndrome and beyond.
Lacombe V; Hadjadj J; Georgin-Lavialle S; Lavigne C; Geneviève F; Kosmider O
Lancet Haematol; 2024 Feb; 11(2):e160-e167. PubMed ID: 38302223
[TBL] [Abstract][Full Text] [Related]
30. Vacuoles, E1 enzyme, X-linked, autoinflammatory, and somatic syndrome in the intensive care unit: a case report.
Belicard F; Belhomme N; Bouzy S; Saillard C; Nedelec F; Mear JB; Ardois S; Pastoret C; Reizine F; Camus C; Painvin B
J Med Case Rep; 2023 Jul; 17(1):314. PubMed ID: 37480098
[TBL] [Abstract][Full Text] [Related]
31. Clonal Hematopoiesis, Inflammation, and Hematologic Malignancy.
Kanagal-Shamanna R; Beck DB; Calvo KR
Annu Rev Pathol; 2024 Jan; 19():479-506. PubMed ID: 37832948
[TBL] [Abstract][Full Text] [Related]
32. VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management.
Koster MJ; Lasho TL; Olteanu H; Reichard KK; Mangaonkar A; Warrington KJ; Patnaik MM
Am J Hematol; 2024 Feb; 99(2):284-299. PubMed ID: 37950858
[TBL] [Abstract][Full Text] [Related]
33. Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.
Georgin-Lavialle S; Terrier B; Guedon AF; Heiblig M; Comont T; Lazaro E; Lacombe V; Terriou L; Ardois S; Bouaziz JD; Mathian A; Le Guenno G; Aouba A; Outh R; Meyer A; Roux-Sauvat M; Ebbo M; Zhao LP; Bigot A; Jamilloux Y; Guillotin V; Flamarion E; Henneton P; Vial G; Jachiet V; Rossignol J; Vinzio S; Weitten T; Vinit J; Deligny C; Humbert S; Samson M; Magy-Bertrand N; Moulinet T; Bourguiba R; Hanslik T; Bachmeyer C; Sebert M; Kostine M; Bienvenu B; Biscay P; Liozon E; Sailler L; Chasset F; Audemard-Verger A; Duroyon E; Sarrabay G; Borlot F; Dieval C; Cluzeau T; Marianetti P; Lobbes H; Boursier G; Gerfaud-Valentin M; Jeannel J; Servettaz A; Audia S; Larue M; Henriot B; Faucher B; Graveleau J; de Sainte Marie B; Galland J; Bouillet L; Arnaud C; Ades L; Carrat F; Hirsch P; Fenaux P; Fain O; Sujobert P; Kosmider O; Mekinian A; ;
Br J Dermatol; 2022 Mar; 186(3):564-574. PubMed ID: 34632574
[TBL] [Abstract][Full Text] [Related]
34. VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases.
Vitale A; Caggiano V; Bimonte A; Caroni F; Tosi GM; Fabbiani A; Renieri A; Bocchia M; Frediani B; Fabiani C; Cantarini L
Intern Emerg Med; 2023 Apr; 18(3):711-722. PubMed ID: 36662445
[TBL] [Abstract][Full Text] [Related]
35. VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia.
Austestad J; Madland TM; Sandnes M; Haslerud TM; Benneche A; Reikvam H
Case Rep Hematol; 2023; 2023():6551544. PubMed ID: 36879894
[TBL] [Abstract][Full Text] [Related]
36. The VEXAS Syndrome: Uncontrolled Inflammation and Macrocytic Anaemia in a 77-Year-Old Male Patient.
Himmelmann A; Brücker R
Eur J Case Rep Intern Med; 2021; 8(4):002484. PubMed ID: 33987129
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort.
Gurnari C; Pascale MR; Vitale A; Diral E; Tomelleri A; Galossi E; Falconi G; Bruno A; Crisafulli F; Frassi M; Cattaneo C; Bertoli D; Bernardi M; Condorelli A; Morsia E; Poloni A; Crisà E; Caravelli D; Triggianese P; Brussino L; Battipaglia G; Bindoli S; Sfriso P; Caroni F; Dragani M; Mallegni F; Pilo F; Firinu D; Curti A; Papayannidis C; Olivieri A; Kordasti S; Albano F; Pane F; Musto P; Bocchia M; Lugli E; Breccia M; Frigeni M; Dagna L; Greco R; Franceschini F; Campochiaro C; Cantarini L; Voso MT
Am J Hematol; 2024 Feb; 99(2):254-262. PubMed ID: 38108611
[TBL] [Abstract][Full Text] [Related]
38. VEXAS syndrome: A review of cutaneous findings and treatments in an emerging autoinflammatory disease.
Saad AJ; Patil MK; Cruz N; Lam CS; O'Brien C; Nambudiri VE
Exp Dermatol; 2024 Mar; 33(3):e15050. PubMed ID: 38469984
[TBL] [Abstract][Full Text] [Related]
39. VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder.
Huang H; Zhang W; Cai W; Liu J; Wang H; Qin T; Xu Z; Li B; Qu S; Pan L; Huang G; Gale RP; Xiao Z
Exp Hematol Oncol; 2021 Mar; 10(1):23. PubMed ID: 33741056
[TBL] [Abstract][Full Text] [Related]
40. Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases.
Jachiet V; Ricard L; Hirsch P; Malard F; Pascal L; Beyne-Rauzy O; Peterlin P; Maria ATJ; Vey N; D'Aveni M; Gourin MP; Dimicoli-Salazar S; Banos A; Wickenhauser S; Terriou L; De Renzis B; Durot E; Natarajan-Ame S; Vekhoff A; Voillat L; Park S; Vinit J; Dieval C; Dellal A; Grobost V; Willems L; Rossignol J; Solary E; Kosmider O; Dulphy N; Zhao LP; Adès L; Fenaux P; Fain O; Mohty M; Gaugler B; Mekinian A;
Clin Exp Med; 2023 Jul; 23(3):803-813. PubMed ID: 35953763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]